Global Imbalances in Funding Sources for HIV Randomized Control Trials
AIDS Research and Human Retroviruses · 2023
DOI: 10.1089/aid.2022.0068 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIDS Research and Human Retroviruses, 2023. Verfasst von Daniel Owoicholofu John und 3 weiteren Autor:innen. Beteiligte Einrichtung: Independent Researcher, Abuja, Nigeria. Hauptthemen laut MEDLINE: Acquired Immunodeficiency Syndrome, HIV Infections. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.
Abstract (Originalsprache)
Improving access to grant funding is a critical aspect of strengthening research capacity outside of higher income settings, particularly in HIV/AIDS where randomized control trials (RCTs) that require substantial resources are common. In this article, we assessed recent RCTs to examine variation in how studies were funded, depending on study location and the countries where publication authors were based. We conducted a PubMed literature review to identify RCTs with HIV status or viral load endpoints published in 2019 and 2020, then analyzed cross-tabulations of funding sources by study characteristics. One hundred sixteen publications met the inclusion criteria. Research in higher income countries was most likely to be funded by biotech/pharmaceutical companies, whereas research in lower- and middle-income countries was most likely to be funded by U.S. government sources. Overall, we found the distribution of funding sources differed significantly by study and author location ( χ 2 = 23, p < .001). Published RCTs with HIV status or viral load endpoints are financed differently based on where studies take place and where the authors are based. As part of future research, understanding why this variation exists is critical for assessing how funding contributes to global imbalances in scientific resources.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Independent Researcher, Abuja, Nigeria.
- Rutgers School of Public Health, Piscataway, New Jersey, USA.
- Faculty of Medicine and Dentistry, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
ORCID-Profile: Mark McGovern
Förderung
- NCATS NIH HHS
Zitieren
APA
John, D. O., Wang, P., Togo, Y., & McGovern, M. (2023). Global Imbalances in Funding Sources for HIV Randomized Control Trials. AIDS Research and Human Retroviruses. https://doi.org/10.1089/aid.2022.0068
Vancouver
John DO, Wang P, Togo Y, McGovern M. Global Imbalances in Funding Sources for HIV Randomized Control Trials. AIDS Research and Human Retroviruses. 2023. doi:10.1089/aid.2022.0068
BibTeX
@article{John2023,
author = {John, Daniel Owoicholofu and Wang, Peng and Togo, Yaya and McGovern, Mark},
title = {Global Imbalances in Funding Sources for HIV Randomized Control Trials},
journal = {AIDS Research and Human Retroviruses},
year = {2023},
doi = {10.1089/aid.2022.0068}
}
EUVIMED